Mortality due to COVID-19 infection: A comparison of first and second waves

References

• Cuschieri S, Balzan M, Gauci C, et al. Mass Events Trigger Malta's Second Peak After Initial Successful Pandemic Suppression. J Community Health. 2021;46(3):618-25.
   Google Scholar
• Chowkwanyun M, Reed AL. Racial Health Disparities and Covid-19 — caution and Context. N Engl J Med. 2020;383(3):201–203.
   PubMed Web of Science ®Google Scholar
• Yancy CW. COVID-19 and african americans. Jama. 2020;323(19):1891–1892.
   PubMed Web of Science ®Google Scholar
• Garg S, Kim L, Whitaker M, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019—COVID-NET, 14 States, March 1–30, 2020. Morbidity Mortality Weekly Rep. 2020;69(15):458.
   PubMed Web of Science ®Google Scholar
• Saito S, Asai Y, Matsunaga N, et al. First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics. J Infect. 2021 Apr 1;82(4):84-123.
   Google Scholar
• Contou D, Fraissé M, Pajot O, et al. Comparison between first and second wave among critically ill COVID-19 patients admitted to a French ICU: no prognostic improvement during the second wave? Crit Care. 2021;25(1):1–4.
   Web of Science ®Google Scholar
• Iftimie S, López-Azcona AF, Vallverdú I, et al. First and second waves of coronavirus disease-19: a comparative study in hospitalized patients in Reus, Spain. PloS one. 2021;16(3):e0248029.
   Google Scholar
• Borghesi A, Golemi S, Carapella N, et al., Lombardy, Italy: COVID-19 second wave less severe than the first? A preliminary investigation. 2020;
   Google Scholar
• RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med. 2021;384(8):p. 693–704.
   PubMed Web of Science ®Google Scholar
• Yao X, Ye F, Zhang M, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clinl Infect Dis. 2020;71(15):732–739.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). Request for emergency use authorization for use of chloroquine phosphate or hydroxychloroquine sulfate supplied from the strategic national stockpile for treatment of 2019 coronavirus disease. [ cited 2021 May 27]; Available from: https://www.fda.gov/media/136534/download.
   Google Scholar
• Self WH, Semler MW, Leither LM, et al. Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19: a Randomized Clinical Trial. JAMA. 2020;324(21):2165–2176.
   PubMed Web of Science ®Google Scholar
• Food and Drug Administration (FDA). Letter revoking EUA for chloroquine phosphate and hydroxychloroquine sulfate. [ cited 2021 May 27]; Available from: https://www.fda.gov/media/138945/download.
   Google Scholar
• Ward S, Lindsley A, Courter J, et al. Clinical testing for COVID-19. J Allergy Clin Immunol. 2020;146(1):23–34.
   PubMed Web of Science ®Google Scholar
• Fields BKK, Demirjian NL, Gholamrezanezhad A. Coronavirus Disease 2019 (COVID-19) diagnostic technologies: a country-based retrospective analysis of screening and containment procedures during the first wave of the pandemic. Clin Imaging. 2020;67:219–225.
   Web of Science ®Google Scholar
• Lepper PM, Muellenbach RM. Mechanical ventilation in early COVID-19 ARDS. EClinicalMedicine. 2020;28.
   Google Scholar
• Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020;46(5):p. 854–887.
   PubMed Web of Science ®Google Scholar
• Bertaina M, Nuñez-Gil IJ, Franchin L, et al. Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: a subanalysis from the HOPE COVID-19 registry. Emer Med J. 2021;38(5):p. 359–365.
   Web of Science ®Google Scholar
• Menzella F, Barbieri C, Fontana M, et al. Effectiveness of noninvasive ventilation in COVID-19 related-acute respiratory distress syndrome. Clin Respir J. 2021;15(7):779–787.
   Web of Science ®Google Scholar
• Holleran (Community Engagement Research& Consulting). Berks County Health Collaborative Community Health Needs Assessment- Final Summary report. 2016 [cited 2021 May 27]; Available from: https://reading.towerhealth.org/app/files/public/308/2016chna.pdf.
   Google Scholar
• Podewils LJ, Burket TL, Mettenbrink C, et al. Disproportionate incidence of COVID-19 infection, hospitalizations, and deaths among persons identifying as Hispanic or Latino—Denver, Colorado March–October 2020. Morbidity Mortality Weekly Rep. 2020;69(48):p. 1812.
   Web of Science ®Google Scholar
• Millett GA, Jones AT, Benkeser D, et al. Assessing differential impacts of COVID-19 on black communities. Ann Epidemiol. 2020;47:37–44.
   PubMed Web of Science ®Google Scholar
• Gold JA, Wong KK, Szablewski CM, et al. Characteristics and clinical outcomes of adult patients hospitalized with COVID-19—Georgia, March 2020. Morbidity Mortality Weekly Rep. 2020;69(18):545.
   Web of Science ®Google Scholar
• van Paassen J, Vos JS, Hoekstra EM, et al. Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes. Crit Care. 2020;24(1):1–22.
   Web of Science ®Google Scholar
• Cano EJ, Fuentes XF, Campioli CC, et al.Impact of corticosteroids in COVID-19 outcomes: systematic review and meta-analysis. Chest. 2021;159(3):1019-1040.
   Google Scholar